Mitochondrial damage triggers therapy-induced senescence
Chrysiida Baltira(The Netherlands Cancer Institute), Mark C. de Gooijer(Manchester Academic Health Science Centre), Ferhat Alkan(The Netherlands Cancer Institute), Míriam Guillén Navarro(Amsterdam UMC Location Vrije Universiteit Amsterdam), William J. Faller(Oncode Institute), Isabel Mayayo‐Peralta(The Netherlands Cancer Institute), René Bernards(The Netherlands Cancer Institute), Olaf van Tellingen(The Netherlands Cancer Institute), Bram Thijssen(The Netherlands Cancer Institute), Anna Their(Dutch Cancer Society), Jos H. Beijnen(The Netherlands Cancer Institute), Onno B. Bleijerveld(Oncode Institute), Fleur Jochems(The Netherlands Cancer Institute), Hans Janßen(KU Leuven), Laura E. Kuil(The Netherlands Cancer Institute), Kimberley Pello(Dutch Cancer Society), Kicky Rozing(The Netherlands Cancer Institute), Daria M. Fedorushkova(Dutch Cancer Society), Rose Lempers(The Netherlands Cancer Institute), Joana Silva(The Netherlands Cancer Institute)
Cited by 0
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence
|Nature Cell Biology|2006|610